Clinical Trial Shows Teriflunomide Pill Reduces Relapses in Relapsing-Remitting MS (1)/About-the-Society/News/Clinical-Trial-Shows-Teriflunomide-Pill-Reduce-(1) … read morePosted At: National MS Society
Latest Research and Solutions for People with MS Presented at the CMSC Meeting/About-the-Society/News/Latest-Research-and-Solutions-for-People-with-MS-P … read morePosted At: National MS Society
The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis
The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosisMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
What you should know about neurosarcoidosisA look at neurosarcoidosis, an inflammatory disease that can affect most organs in the body. Included is detail on outlook and the causes compared to MS. … read morePosted...
New Study Reports That an Online Community of People with MS May Be Used to Study the Disease/About-the-Society/News/Profiles-of-People-Living-with-MS … read morePosted At: National MS Society
- Next story Ginkgo Fails to Improve Cognitive Function in People with MS
- Previous story FDA Approves Oral Teriflunomide – Brand Name Aubagio® – as Disease-Modifying Therapy for Relapsing M
Join Our Mailing List
- Guidelines Released by AAN to Help Inform Treatment Choices for Multiple Sclerosis
- Why are my legs and feet numb?
- MS News from the AAN Meeting in Los Angeles
- How to beat psoriasis at its own game
- How can CBD help with fibromyalgia?
- Physical and mental benefits of swimming
- National MS Society Commits $14.2 Million to New Research to Stop Multiple Sclerosis, Restore Functi
- Novel PET imaging agent could help guide therapy for brain diseasesPosted At: Science Daily
- 2018 John Dystel Prize for MS Research Goes to Prof. Frederik Barkhof – A Leader in Using MRI to St
- Congress Passes FY 2018 Budget